Healthgen Biotechnology Corp.

Quick facts

Phase 3 pipeline

• OsrHSA
  OsrHSA is a recombinant human serum albumin fusion protein designed to extend the half-life and improve the pharmacokinetics of a therapeutic payload.
• Plasbumin®-20 · Critical Care; Hematology
  Plasbumin-20 is a human serum albumin solution that acts as a plasma volume expander and colloid to restore intravascular oncotic pressure and improve tissue perfusion.

Phase 2 pipeline

• OrsHSA

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Healthgen Biotechnology Corp. portfolio CI brief
• Healthgen Biotechnology Corp. pipeline updates RSS